# Windward Bio Group AG (WWB)

Source: https://www.quantisnow.com/company/WWB
Generated: 2026-11-19T03:00:54.336Z

- Ticker: WWB
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2026
- SEC CIK: 0002145089

## About

Windward Bio Group is a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease, or COPD, and atopic dermatitis. Our product candidates, WIN378 and WIN027, target clinically validated disease pathways and are engineered to remain in the body for extended periods of time, enabling less frequent dosing than currently available treatments. This design feature is combined with additional properties including enhanced target affinity, dual target binding or effector function silencing. We believe our product candidates have the potential to deliver better clinical outcomes while offering the convenience of less frequent dosing than currently available treatments.

## Latest WWB news and filings

- 2026-11-18 22:12 UTC [Insider Buy] [Director David P Bonita bought $20,000,007 worth of shares (1,176,471 units at $17.00), converted options into 5,172,944 shares, exercised 216,668 shares at a strike of $0.02 and covered exercise/tax liability with 232 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-david-p-bonita-bought-20000007-worth-of-shares-1176471-6799292)
- 2026-11-18 22:08 UTC [Insider Buy] [Director Orbimed Advisors Llc bought $20,000,007 worth of shares (1,176,471 units at $17.00), converted options into 5,172,944 shares, exercised 216,668 shares at a strike of $0.02 and covered exercise/tax liability with 232 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-orbimed-advisors-llc-bought-20000007-worth-of-shares-1176471-6799278)
- 2026-11-18 21:30 UTC [Insider Buy] [Director Otello Stampacchia bought $29,750,000 worth of shares (1,750,000 units at $17.00) and converted options into 3,588,520 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-otello-stampacchia-bought-29750000-worth-of-shares-1750000-units-6798997)
- 2026-11-17 21:01 UTC [Windward Bio to Participate at the Jefferies London Global Healthcare Conference](https://www.quantisnow.com/insight/windward-bio-to-participate-at-the-jefferies-london-global-healthcare-6796477)
- 2026-11-16 23:10 UTC [SEC Form 4] [Director Mufti Iqbal Rasool was granted 22,675 share options (SEC Form 4)](https://www.quantisnow.com/insight/director-mufti-iqbal-rasool-was-granted-22675-share-options-sec-6795020)
- 2026-11-16 23:00 UTC [SEC Form 4] [Chief Operating Officer Harris Kevin Andrew was granted 33,206 shares, increasing direct ownership by 4% to 960,966 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-harris-kevin-andrew-was-granted-33206-shares-6795006)
- 2026-11-16 23:00 UTC [SEC Form 4] [Chief Executive Officer Santarelli Luca was granted 815,755 employee share options (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-santarelli-luca-was-granted-815755-employee-share-6795004)
- 2026-11-16 23:00 UTC [SEC Form 4] [Chief Financial Officer D'Augusta Claudia was granted 180,160 employee share options (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-daugusta-claudia-was-granted-180160-employee-share-6795001)
- 2026-11-16 23:00 UTC [SEC Form 4] [Director Bonita David P was granted 22,675 stock options (SEC Form 4)](https://www.quantisnow.com/insight/director-bonita-david-p-was-granted-22675-stock-options-sec-6794998)
- 2026-11-16 23:00 UTC [SEC Form 4] [Director Stampacchia Otello was granted 22,675 share options (SEC Form 4)](https://www.quantisnow.com/insight/director-stampacchia-otello-was-granted-22675-share-options-sec-form-6794993)
- 2026-11-16 23:00 UTC [SEC Form 4] [Director Kapadia Sandip was granted 100,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-kapadia-sandip-was-granted-100000-shares-sec-form-4-6794990)
- 2026-11-16 23:00 UTC [SEC Form 4] [Chief Medical Officer Khwaja Omar was granted 219,030 employee share options (SEC Form 4)](https://www.quantisnow.com/insight/chief-medical-officer-khwaja-omar-was-granted-219030-employee-share-6794989)
- 2026-11-16 23:00 UTC [SEC Form 4] [Chief Legal & Corp Dev Officer Applebaum Scott was granted 33,206 shares, increasing direct ownership by 4% to 960,966 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-legal-corp-dev-officer-applebaum-scott-was-granted-33206-6794986)
- 2026-11-16 22:22 UTC [SEC Form 6-K] [SEC Form 6-K filed by Windward Bio Group AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-windward-bio-group-ag-6794875)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/WWB
- Earnings history: https://www.quantisnow.com/earnings/WWB
- Dividend history: https://www.quantisnow.com/dividends/WWB
- Insider transactions: https://www.quantisnow.com/insiders/WWB
- Options chain: https://www.quantisnow.com/options/WWB
- SEC 8-K filings only: https://www.quantisnow.com/company/WWB/8-k
- RSS and alerts for WWB: https://www.quantisnow.com/docs/rss-feeds.md
